{
    "clinical_study": {
        "@rank": "107603", 
        "arm_group": [
            {
                "arm_group_label": "KWA-0711 Dose1", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "KWA-0711 Dose2", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "KWA-0711 Dose3", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "KWA-0711 Dose4", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the efficacy and safety of tapered KWA-0711 dose in\n      chronic constipation patients."
        }, 
        "brief_title": "A Single-blind, Dose-tapering Study of KWA-0711 in Patients With Chronic Constipation", 
        "condition": "Chronic Constipation", 
        "condition_browse": {
            "mesh_term": "Constipation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The patients who experienced fewer than three spontaneous bowel movements per week\n             for more than 6 months prior to the enrollment.\n\n          -  The patients who experienced one or more of the following signs or symptoms during\n             more than 25% of bowel movements for more than 6 months: straining, lumpy or hard\n             stools, and a sensation of incomplete evacuation\n\n        Exclusion Criteria:\n\n          -  Patients who have secondary constipation caused by systemic disorder.\n\n          -  Patients who have organic constipation.\n\n          -  Patients who received intestinal resection."
            }, 
            "gender": "Both", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "firstreceived_date": "August 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01937663", 
            "org_study_id": "KWA1203"
        }, 
        "intervention": {
            "arm_group_label": [
                "KWA-0711 Dose1", 
                "KWA-0711 Dose2", 
                "KWA-0711 Dose3", 
                "KWA-0711 Dose4"
            ], 
            "intervention_name": "KWA-0711", 
            "intervention_type": "Drug"
        }, 
        "keyword": [
            "Chronic Constipation", 
            "Constipation", 
            "Functional gastrointestinal disorders"
        ], 
        "lastchanged_date": "May 29, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tokyo", 
                    "country": "Japan"
                }
            }
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Japan: Ministry of Health, Labor and Welfare"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Frequency of Spontaneous Bowel Movements\nBowel Movement Timing\nStool Consistency\nAbdominal Assessment\nQOL Assessment", 
            "measure": "Improvement of signs and symptoms associated with constipation", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01937663"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Kissei Pharmaceutical Co., Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kissei Pharmaceutical Co., Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "N/A", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}